首页> 外国专利> Crystalline form of cefamandole nafate compound, preparation and preparing method thereof

Crystalline form of cefamandole nafate compound, preparation and preparing method thereof

机译:头孢曼陀烷萘酸盐化合物的晶型,制备方法及制备方法

摘要

A novel crystalline form is defined by diffraction angle 2θ° of X-ray powder diffraction pattern and characteristic peak of differential scanning calorimetry (DSC). The novel crystalline form of Cefamandole Nafate is prepared as follows: adding Cefamandole Nafate in solid state to an organic solvent to form a suspension with a concentration of 0.04˜0.3 g/ml, stirring the suspension at 40˜50° C. for a period of time, and then cooling to 5˜15° C. at certain cooling rate, continuing to stir for a period of time, then suction filtrating the obtained suspension, the resulting filer cake is Cefamandole Nafate as wet product, which is dried to constant weight to provide the novel crystalline form of Cefamandole Nafate as final product.
机译:X射线粉末衍射图的衍射角2θ°和差示扫描量热法(DSC)的特征峰定义了一种新的晶体形式。头孢曼多夫萘酸盐的新型结晶形式如下:将头孢曼多夫萘酸盐固态添加至有机溶剂中形成浓度为0.04〜0.3g / ml的悬浮液,在40〜50℃下搅拌一段时间。时间,然后以一定的冷却速度冷却至5〜15°C,持续搅拌一段时间,然后抽滤得到的悬浮液,得到的滤饼为湿润产物头孢曼多夫萘酸盐,将其干燥至恒定重量,以提供新的结晶形式的头孢万多萘酸酯作为最终产物。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号